AIM IMMUNOTECH INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $26.0K | — | $22.0K | — | — | — | $26.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $589.0K | — | $482.0K | — | — | — | $607.0K |
| SG&A Expense | — | $2.9M | — | $1.8M | — | — | — | $1.8M |
| Operating Income | — | $-3.5M | — | $-2.2M | — | — | — | $-2.4M |
| Operating Margin | — | -13,511.5% | — | -10,118.2% | — | — | — | -9,411.5% |
| Interest Expense | — | $295.0K | — | $304.0K | — | — | — | $148.0K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-3.8M | — | $-3.0M | — | — | — | $-3.3M |
| Net Margin | — | -14,569.2% | — | -13,740.9% | — | — | — | -12,630.8% |
| EPS (Basic) | — | $-0.43 | — | $-0.69 | — | — | — | $0.52 |
| EPS (Diluted) | — | $-0.43 | — | $-0.69 | — | — | — | $0.52 |
| Shares Outstanding (Basic) | 30.4M | 17.1M | 14.6M | 4.4M | 8.1M | 3.1M | 8.6M | 6.3M |
| Shares Outstanding (Diluted) | 30.4M | 17.1M | 14.6M | 4.4M | 8.1M | 3.1M | 8.6M | 6.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |